Acton, MA, United States of America

John S Petersen

USPTO Granted Patents = 40 


 

Average Co-Inventor Count = 2.0

ph-index = 13

Forward Citations = 637(Granted Patents)


Company Filing History:


Years Active: 1993-2022

Loading Chart...
Loading Chart...
Loading Chart...
40 patents (USPTO):Explore Patents

Title: Innovations by John S. Petersen in MetAP2 Inhibitors

Introduction

John S. Petersen, based in Acton, MA, is a prolific inventor with an impressive portfolio of 40 patents. His research primarily focuses on the development of MetAP2 inhibitors, which have significant implications for treating obesity and metabolic disorders. His inventions seek to advance therapeutic methods in weight management and metabolic health.

Latest Patents

Among his latest innovations are patents concerning modified or polymer-conjugated MetAP2 inhibitors. These inventions relate to methods for preventing and treating obesity, improving insulin sensitivity, and enhancing glycemic control. The inventive approach combines pharmacological compounds with polymer conjugation to enhance efficacy and pharmacokinetic properties. His patents explore various therapeutic applications of these inhibitors, demonstrating a commitment to advancing medical treatments relevant to metabolic syndrome.

Career Highlights

Throughout his career, John has worked with notable companies such as Syndevrx, Inc. and Geltex Pharmaceuticals, Inc. His contributions have accelerated research and development efforts in the pharmaceutical sector, particularly in new therapeutic methodologies that are vital for patient care in obesity-related health issues.

Collaborations

John Petersen has collaborated with esteemed professionals in his field, including Stephen Randall Holmes-Farley and Pradeep K. Dhal. These partnerships have enriched his research endeavors and have contributed to the successful development of innovative therapeutic strategies.

Conclusion

John S. Petersen stands out as a leading inventor in the field of MetAP2 inhibitors, with a substantial number of patents that reflect his dedication to advancing scientific knowledge and healthcare solutions. His latest work continues to hold promise for improving the treatment landscape for obesity and related metabolic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…